According to a report by The Wall Street Journal on January 31, GE Healthcare announced its first earnings report as a listed company. The profit for the fourth quarter of 2022 decreased year-on-year, while revenue achieved growth. The company stated that net profit fell by 1.8% to US$554 million, and earnings per share from continuing operations dropped from US$1.24 to US$1.21. The company completed its spin-off transaction from General Electric Company on January 3, 2023. Excluding special items, adjusted earnings per share decreased from US$1.36 to US$1.31, and standalone adjusted earnings per share including independent costs were US$1.21.
Revenue increased by 7.6% to reach $4.94 billion. The cost of sales for products and services grew by 10.2% to $3.01 billion, surpassing the revenue growth, causing the gross margin to contract from 40.6% to 39.1%. The company expects adjusted earnings per share for 2023 to be between $3.60 and $3.75, up from $3.38 in 2022 on an adjusted standalone basis.